Invention Application
US20170022192A1 AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES
有权
用作IL-12，IL-23和/或IFN ALPHA反应的调节剂的酰胺取代的杂环化合物
- Patent Title: AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES
- Patent Title (中): 用作IL-12，IL-23和/或IFN ALPHA反应的调节剂的酰胺取代的杂环化合物
-
Application No.: US15289437Application Date: 2016-10-10
-
Publication No.: US20170022192A1Publication Date: 2017-01-26
- Inventor: Ryan M. Moslin , David S. Weinstein , Stephen T. Wrobleski , John S. Tokarski , Amit Kumar , Douglas G. Batt , Shuqun Lin , Chunjian Liu , Steven H. Spergel , Yanlei Zhang , Qingjie Liu
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Main IPC: C07D417/14
- IPC: C07D417/14 ; C07B59/00 ; C07D403/12 ; C07D413/14 ; C07D403/14 ; C07D401/14 ; C07D417/12 ; C07D413/12 ; C07D401/12 ; C07D237/24
Abstract:
Compounds having the following formula I: or a stereoisomer or pharmaceutically-acceptable salt thereof, where R1, R2, R3, R4, and R5 are as defined herein, are useful in the modulation of IL-12, IL-23 and/or IFNα, by acting on Tyk-2 to cause signal transduction inhibition.
Public/Granted literature
- US10000480B2 Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses Public/Granted day:2018-06-19
Information query
